Blood pressure fluctuations predict risk of heart attack and stroke
Imperial College London (ICL) - 31-Jan-2024Study calls for effective monitoring and amlodipine-based treatment plan
Join the club for FREE to access the whole archive and other member benefits.
Professor of Clinical Pharmacology & Therapeutics and Honorary Consultant Physician at the Imperial
Peter Sever is Professor of Clinical Pharmacology and Therapeutics at Imperial College London, Honorary Consultant Physician at the Imperial Healthcare NHS Trust and Co-Director of the International Centre for Circulatory Health. His current research interests in cardiovascular disease include the pathophysiology of vascular disease, the evaluation of anti-hypertensive drug therapy and multiple risk factor intervention in hypertensive populations.
After graduating from Cambridge, Sever completed his training at St Mary’s Hospital Medical School. Following a succession of appointments in general medicine, cardiology and chest diseases, followed by lectureships in medicine and pharmacology, he became an Honorary Consultant Physician and Senior Lecturer in Medicine in the Medical Unit at St Mary’s Hospital in 1976. In 1980 he was appointed Professor of Clinical Pharmacology and Therapeutics at St Mary’s Hospital Medical School, which was subsequently incorporated into the Imperial College School of Medicine.
Visit website: https://www.imperial.nhs.uk/consultant-directory/peter-sever
See also: Imperial College London (ICL) - Public research university with an international reputation for excellence in teaching and research
Details last updated 03-Feb-2024
NHS trusts in England and together with Imperial College London forms an academic health science centre.
Study calls for effective monitoring and amlodipine-based treatment plan